Operating activities: | |
Net income | -94.06M |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Depreciation | 10.7M |
Stock-based compensation expense | 5.68M |
Amortization of intangible assets | |
Amortization of deferred financing costs | |
Deferred income taxes | 2K |
Write off of deferred financing costs | |
Excess tax benefit from stock-based compensation arrangements | |
Non-cash restructuring charges | |
Other | 2.3M |
Changes in assets and liabilities (net of acquisitions): | |
Accounts receivable | 4.69M |
Inventories | -22.1M |
Prepaid expenses and other current assets | 1.91M |
Accounts payable | 6.61M |
Accrued expenses and other liabilities | 20.02M |
Net cash provided by operating activities | -51M |
Investing activities: | |
Capital expenditures | -25.75M |
Acquisitions of businesses | 0 |
Purchase of intangible assets | -82K |
Sales and maturities of available-for-sale marketable securities | 2.57M |
Investment in available-for-sale marketable securities | |
Proceeds from sale of assets | |
Net cash used in investing activities | -23.27M |
Financing activities: | |
Issuance of common stock | 1.87M |
Financing under factoring agreement, net | |
Payments of long term borrowings | |
Redemption of convertible senior notes | -240M |
Proceeds from term loan borrowings | |
Payments of deferred financing costs | |
Excess tax benefit from stock-based compensation arrangements | |
Net cash used in financing activities | 276.26M |
Effect of exchange rates on cash and cash equivalents | -1.45M |
Net increase in cash and cash equivalents | 200.54M |
Cash and cash equivalents, beginning of period | |
Cash and cash equivalents, end of period |